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Little is known about the molecular epidemiology of the human pathogenic fungus Cryptococcus neoformans
in India, a country now in the midst of an epidemic of AIDS-related cryptococcosis. We studied 57 clinical
isolates from several regions in India, of which 51 were C. neoformans var. grubii, 1 was C. neoformans var.
neoformans, and 5 were C. neoformans var. gattii. This strain set included 18 additional sequential isolates from
14 patients. Strains were characterized phenotypically by measuring the polysaccharide capsule and by
determining the MICs of standard antifungals. Molecular typing was performed by a PCR-based method using
the minisatellite-specific core sequence (M13), by electrophoretic karyotyping, by restriction fragment length
polymorphisms with the C. neoformans transposon 1 (TCN-1), and by URA5 DNA sequence analysis. Overall,
Indian isolates were less heterogeneous than isolates from other regions and included a subset that clustered
into one group based on URA5 DNA sequence analysis. In summary, our results demonstrate (i) differences in
genetic diversity of C. neoformans isolates from India compared to isolates from other regions in the world; (ii)
that DNA typing with the TCN-1 probe can adequately distinguish C. neoformans var. grubii strains; (iii) that
TCN-1 sequences are absent in many C. neoformans var. gattii strains, supporting previous studies indicating
that these strains have a limited geographical dispersal; and (iv) that human cryptococcal infection can be
associated with microevolution of the infecting strain and by simultaneous coinfection with two distinct
C. neoformans strains.
Cryptococcus neoformans is an encapsulated yeast which causes
life-threatening infections in approximately 2 to 3% of patients
with AIDS in the United States (42) and in up to 40% of AIDS
patients in Africa (www.who.int/hiv/; 2004 data). Meningoen-
cephalitis is the most common and serious clinical manifestation
of C. neoformans infection and can be refractory to antifungal
therapy (50). In the absence of immune reconstitution with
antiretroviral therapy, the initial presentation requires lifelong
suppressive antifungal treatment to reduce the likelihood of
recurrent cryptococcosis. Genetic differences among C. neofor-
mans strains have been detected by several typing methods,
including restriction fragment length polymorphism (RFLP)
analysis (18, 20), electrophoretic karyotyping (7, 20, 24), allele
sequencing (15), multilocus enzyme electrophoresis (9, 10),
and random amplified polymorphic DNA analysis (6, 8, 9).
Understanding the genetic variation of a pathogen population
is important because it could translate into differences in the
host’s immunogenic response and therefore become a major
consideration in vaccine design. In addition, genetic variation
could affect the function of important genes and thereby affect
virulence. Furthermore, knowledge of genetic variation is es-
sential for understanding the population structure and evolu-
tion of a microorganism (55).
The tropical climate of the Indian subcontinent offers a
suitable environment for Cryptococcus neoformans, and the
onslaught of the AIDS pandemic since the early 1990s has
led to a sharp increase in the number of reported cases of
cryptococcosis in the past decade (3–5). In India, this num-
ber is likely to be an underestimate because cryptococcosis
is not a reportable disease. Furthermore, since India’s pop-
ulation exceeds one billion and because aggressive retroviral
therapy may not be available for all affected individuals, the
absolute numbers of infected patients at risk for AIDS-
related cryptococcosis in the near future are likely to be very
high. The wide variety of presentations of the disease seen in
India suggests the possibility of strain variation. In a finding
similar to that of an Australian survey (17), many of the
Indian cases occur in patients with no obvious impairment
of the immune system (2). Furthermore, the distribution of
serotypes in Indian clinical isolates appears to be different
from that found in other regions, with the majority of the
Indian isolates being serotype A and a significant minority
being serotype B (2). Since India, the most densely popu-
lated country in the world, is facing a significant increase in
AIDS cases and cryptococossis, undertaking a detailed in-
vestigation of the C. neoformans strains is warranted. The
current study was undertaken to investigate the molecular
epidemiology of C. neoformans infection in India and yields
important results about C. neoformans strains from this part
of the world.
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MATERIALS AND METHODS
Cryptococcal isolates. A total of 57 clinical Indian C. neoformans isolates,
which were derived from a total of 39 patients, were included in the study. The
isolates originated either from patients admitted to All India Institute of Medical
Sciences (AIIMS) in Delhi or were sent for identification to AIIMS from dif-
ferent cities in India (this includes one isolate that was sent from Nepal). All
clinical isolates were obtained over a 1-year period. All clinical isolates were
identified as C. neoformans by brown colony color in bird seed agar, positive
urease test, sugar assimilation test, and ability to grow at 37°C. Isolates that
produced black colonies in L–3,4-dihydroxyphenylalaline (L-DOPA) agar were
identified as C. neoformans var. neoformans or var. grubii on the basis of no color
change on canavanine-glycine-bromothymol blue agar (25). Mating type was
determined by amplifying Mat-specific sequences as described previously (28).
C. neoformans strains H99 (serotype A), 24064 (serotype A), 24067 (serotype
D), J11 (serotype A), B3501 (serotype D), JEC21 (serotype D), and SB4 (sero-
type A) were used as reference strains for RFLP typing. For RFLP typing and for
URA5 sequence comparison of C. neoformans var. gattii strains, DNA was iso-
lated from 12 environmental isolates and 1 clinical isolate from Australia
(AS2559, AS2557, AS2554, AS2552, AS1337, AS2553, AS2561, AS2551, AS2555,
AS2556, AS2558, AS2560, and AS2562), 5 clinical isolates from Canada
(CN2615, CN2611, CN2613, CN2618, and CN2617), and 1 clinical serotype C
isolate from New York (NY1343C) (generous gift from Tom Mitchell). Further-
more, the URA5 DNA sequence was downloaded (see below) for seven New
York City isolates (J15, J17, J19, J21, J24, J25, and J28) and on five Brazilian
strains (BZ1, BZ2, BZ3, BZ4, and BZ5), of which all but the J21 strain (serotype
D) were serotype A strains.
Capsule measurement and staining. Capsule size of in vitro-grown yeast cells
was examined at a magnification 100 under oil in an India ink suspension. The
distance from the cell wall to the outer margin capsule and the cell diameter (not
including the capsule) was measured using an eyepiece grid with a resolution of
0.5 m. The polysaccharide capsule of unfixed yeast cells was stained with a
monoclonal antibody (MAb) to glucuronoxylomannan 12A1 and an isotype-
specific fluorescein-labeled secondary MAb (51).
In vitro antifungal susceptibility testing. The MICs for amphotericin B and
fluconazole were determined by CLSI (formerly NCCLS) M27-A methodology
(48, 49). As a quality control measure, the results were considered valid only
when the MICs of the quality control isolates fell within the prespecified ranges:
Candida parapsilosis ATCC 22019 (fluconazole, 2 to 8 mg/liter) and Candida
krusei ATCC 6258 (fluconazole, 16 to 64 mg/liter). Prior to testing, each isolate
was subcultured at least twice on Sabouraud’s dextrose agar plates to ensure
purity and optimal growth. Suspensions were prepared in 0.85% saline to achieve
1 McFarland standard adjusted by spectrophotometer measurement. A working
solution was prepared by a 1:1,000 dilution in RPMI 1640 buffered with mor-
pholinepropanesulfonic acid. The working cell suspension (0.9 ml) was added to
0.1 ml of a 10-fold dilution of drug ranging from 1.25 to 640 g/ml and 0.03 to
40 g/ml for fluconazole and amphotericin B, respectively. The tubes were
incubated at 30°C for 48 h. The MIC was determined as the lowest concentration
that produced at least 80% inhibition compared to the growth of the control tube
for fluconazole and the absence of visible growth in the case of amphotericin B.
The 80% inhibition standard for fluconazole was prepared by diluting 0.2 ml of
drug-free control growth with 0.8 ml of RPMI medium. The turbidity was then
compared both visually and spectrophotometrically.
Genomic DNA isolation. C. neoformans DNA was isolated by using a modifi-
cation of an existing protocol (22). Briefly, protoplasts were generated by incu-
bating cells in 10 mg/ml lysing enzyme (from Trichoderma harzianum; Sigma
Aldrich, St. Louis, MO) in 1.0 M sorbitol–0.1 M sodium citrate (pH 5) for 1 to
3 h at 30°C. Protoplasts were lysed in a solution of 5 mM EDTA, 10 mM sodium
citrate, and 1% sarcosine. After 40 min at 65°C, the lysate was extracted twice
with buffer-equilibrated phenol and once with chloroform. DNA was precipi-
tated by the addition of 0.1 volume of 3 M sodium acetate and 2.5 volumes
of ethyl alcohol and was resuspended in 0.01 M Tris-HCl—0.01 M EDTA (pH
8.1).
RAPD analysis. Randomly amplified polymorphic DNA (RAPD) analysis was
done by a PCR-based method using the minisatellite-specific core sequence of
the wild-type phage M13 (5GAGGGTGGCGGTTCT 3) (40) as a single primer
in the PCR. The amplification reactions were performed in a volume of 50 l
containing 25 ng high-molecular-weight genomic DNA, 10 mM Tris-HCl, pH 8.3,
50 mM KCl, 1.5 mM MgCl, 0.2 mM (each) of dATP, dCTP, dGTP, and dTTP,
3 mM magnesium acetate, 30 ng primer, and 2.5 U Amplitaq DNA polymerase
(Applied Biosystems, Foster City, CA). PCR was performed for 35 cycles in a
Perkin-Elmer thermal cycler (model 480) with 1 min of denaturation at 94°C,
1 min of annealing at 50°C, and a 1-min extension at 72°C, followed by a final
extension cycle for 6 min at 72°C. Amplification products were removed, con-
centrated to approximately 20 l, separated by electrophoresis on 1.4% agarose
gels (stained with ethidium bromide, 10 mg/ml stock) in 1 Tris-borate-EDTA
buffer at 60 V for 14 cm, and visualized under UV light. All visible bands were
included in the analysis, independent of their intensity. Band patterns fell into
eight groups. Strains were classified as follows: groups VNI and VNII (serotype
A), VNIII (serotype AD), VN IV (serotype D), and VG I, VG II, VG III, and
VG IV (serotypes B and C) (40).
RFLP analysis. All isolates were typed by Southern blot analysis with a
C. neoformans-specific transposon sequence (TCN-1) (33). Briefly, genomic
DNA was extracted from protoplasts. Fifty micrograms of genomic DNA was
digested with 50 U of EcoRI (Invitrogen) for 4 h at 37°C. The resulting fragments
were resolved on a 1% agarose gel in 0.5 Tris-acetate-EDTA buffer at 32 V for
24 h and transferred to a positively charged nylon membrane. Hybridization with
the labeled TCN probe was done in a solution of denatured salmon sperm DNA
(0.75 mg/ml) in 5 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)
with 7% sodium dodecyl sulfate (SDS), 10Denhardt’s reagent, and 5% dextran
sulfate in 0.02 M sodium phosphate buffer (pH 7.2) at 65°C. Filters were washed
with wash solution 1 (3 SSC, 5% SDS, 10 Denhardt’s reagent) and then wash
solution 2 (1 SSC, 1% SDS) at 65°C. The TCN-1 probe was generated by
amplifying a 634-bp fragment from strain H99 with specific primers (TCN1.F.2
[5-TCATGTCAGGTCCTTCCACTCGTAG-3]) and (TCN1.R.2 [5-CAT
AAACTTGGGCTGGGGATCG-3]). Sequence comparison of the TCN ampli-
con from H99 (serotype A), B3501 (serotype D), and NP-1 (serotype B) dem-
onstrated 94% identical sequence for serotypes A and B and 96% for serotypes
A and D. The TCN amplicon was purified, cloned, and labeled with [-32P]dCTP
using the High Prime DNA labeling kit (Boehringer, Mannheim, Germany). The
bands were visualized by autoradiography. The RFLP patterns were normalized
by equating the 1-kb DNA molecular weight markers (Gibco).
URA5 gene sequencing. The 724-bp (serotypes A and D) and 447-bp (serotype
B) sequence of the URA5 gene (coding for orotidine monophosphate pyrophos-
phorylase) was amplified from genomic DNA by PCR with oligonucleotides (for
serotypes A and D, 5-TTAAGACCTCTGAACACC-3 and 5-ATGTCCTCC
CAAGCCCTC-3; for serotype B, 5-CCGGTCTCCTTTATTCCTCA-3 and
5-AAACCAATRATAGGCTCGAC-3) as described previously (21) and se-
quenced in the DNA sequencing facility at Albert Einstein College of Medicine.
Samples were analyzed by fluorescent cycle sequencing with dye-labeled primers.
The URA5 sequences obtained from the reference strains (17 from C. neofor-
mans var. gattii and 28 from C. neoformans var. neoformans) were compared with
URA5 sequences downloaded from GenBank (GB). These include URA5 se-
quences of seven New York City clinical isolates (GB no. L38582 to L38588,
respectively), 5 Brazilian clinical isolates (GB no. U67723 to U67727, respec-
tively), B-3501 (GB no. M34606), ATCC 24064 (GB no. AF032432), and a
C. neoformans var. gattii reference strain (GB no. M93026).
Chromosomal DNA isolation and electrophoretic karyotyping. Karyotype anal-
ysis was done by contour-clamped homogeneous electrophoresis (CHEF). Chro-
mosomal DNA plugs were prepared from cultures derived from single colonies
as described previously (24). Protoplasts were generated by digesting cells with a
variety of concentrations of lysing enzyme per ml (from Trichoderma harzianum;
Sigma Aldrich) in 1.0 M sorbitol–0.1 M sodium citrate (pH 5) for 1 to 3 h at 30°C.
Proper protoplast formation was verified by phase microscopy prior to proceed-
ing with the isolation of chromosomal DNA. Protoplast-agarose plugs were made
by mixing a protoplast suspension (4  108 to 6  108/ml) with 2% low-melting-
temperature agarose solution (Bio-Rad, Richmond, CA) to yield a final agarose
concentration of 0.66%. Plugs were allowed to harden at 4°C and were then
incubated overnight at 50°C in a solution of 1 mg/ml of proteinase K (Boehringer
Mannheim), 1% sarcosine, and 0.1 M EDTA–0.01 M sodium citrate (pH 8.0).
The plugs were then washed four times in 50 ml of wash buffer (0.05 M EDTA,
0.02 M Tris-HCl [pH 8.0]). After a final wash in 0.1 wash buffer, the plugs were
stored at 4°C until used. The plugs were inserted into a 1% pulse field certified
agarose gel (Bio-Rad), and electrophoresis was done in a CHEF DRIII variable-
angle pulse-field electrophoresis system (Bio-Rad) in 0.5% Tris-borate-EDTA at
12°C. The system was equipped with a cooling module (Bio-Rad) for constant
temperature control. The electrophoresis conditions were programmed in two
sequential blocks. First a switch time of 90 s was applied for 9 h and then a switch
time of 120 s and 360 s for 63 h. Both blocks were run at 3.5 V/cm at an angle
of 115o. Gels were stained with ethidium bromide and photographed.
Data analysis. The karyotype and TCN-1 RFLP patterns of all strains were
compared by visual inspection. The RFLP patterns were normalized by equating
the 1-kb and 100-bp molecular weight markers (Boehringer Mannheim). Simi-
larly, Saccharomyces cerevisiae chromosomal DNA (Bio-Rad, Richmond, CA)
was used in a lane as a reference to normalize the CHEF patterns. Patterns were
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considered identical if all bands matched exactly. Patterns that differed by only
one band were identified as subtypes. Isolates that differed from the others by at
least two bands were assigned to different patterns. Similarity coefficients (S
value) for pairwise analysis between different karyotype patterns were calculated
using the formula S 2NAB /(NA NB)], where NA and NB are the total number
of bands in isolates A and B, respectively, and NAB is the number of common
bands (41).
Phylogenetic reconstruction. To estimate phylogenies, URA5 sequences were
aligned for analysis in Fig. 3 (left panel) and 4 by using Clustal W (1) Nucleotide
sequences were used after removing all alignment gaps. These trees were con-
structed using the neighbor-joining algorithm (p-distance method), and molec-
ular evolutionary analyses were conducted using MEGA version 2.1 (35). For
analysis in Fig. 3 (right panel), URA5 DNA sequences were aligned using
T-COFFEE (44) and the ends were trimmed to remove sparse columns. Phylo-
genetic reconstruction compared the sequences with introns in place and introns
removed (29). Three different methods were used: one PAUP* neighbor-joining
(reconstruction with p-distance (bootstrap, 10,000 replicates), one PAUP* par-
simony bootstrap reconstruction treating gap characters as a fifth base (boot-
strap, 1,000 replicates) (54), and two identical MrBayes reconstructions with the
Hasegawa-Kishino-Yano model (31), 4 rate categories for gamma distribution
(10 million generations, burn in conservatively set at 1 million generations;
sample every 100 generations).
RESULTS
Phenotypic characterization of Indian isolates. We performed
molecular typing on 57 clinical isolates from India that were
cultured from a total of 39 patients (Tables 1 and 2. Eighteen
isolates represented sequential isolates (defined as isolates re-
covered from a patient any time after the primary isolate was
grown) on 14 of the 39 patients (Table 3). Of these patients,
46% were infected with human immunodeficiency virus. The
remaining 54% had negative human immunodeficiency virus
tests and had no known immune defects. Interestingly, all
patients except one were male. The majority (n  47) of
isolates were grown from cerebral spinal fluid (CSF) speci-
mens. Nine isolates were grown from other body fluids includ-
ing blood (n  2), urine (n  3), sputum (n  3), and wound
aspirate (n  1).
By M13 minisatellite RAPD typing, 5 isolates belonged to
group VGII (C. neoformans var. gattii, serotypes B and C), 1
TABLE 1. Characteristics of C. neoformans (serotype A and D) strains from India
Strain Age(yr)a
Source of
sample
Clinical
presentation
HIV
status
URA5
cluster
Pattern determined by: MIC
FLUi
Mating
typeCHEF RFLP
I14 50 Sputum SKIN Negative 1 IV I 24 
I19 42 CSF CMEb Negative 2 SM-IV SM-M 32 
MC-III MC-N 16 
I31 46 CSF HAc Negative 2 I B 8 
I47 36 Sputum COUGH Positive IV H 6 a
I48 7 Blood FUOd Positive 2 III B 8 
I51 25 CSF CME Negative III B 4 
I55 28 CSF FUO Positive III B 32 
I57 45 CSF HA Positive 1 VII G 8 
I58 30 CSF HA Positive 2 VIII G 64 
I61 75 CSF ASe Negative 2 III A 16 
I62 24 CSF CME Positive I B 16 
I64 23 CSF CME Positive 2 III B 32 
I65 18 CSF CME Negative V B 8 
I66 24 CSF FUO, HA Negative IX A 32 
I68 27 CSF CME Positive XIII L 32 
I70 43 CSF FUO Negative 2 XIV B 8 
I71 44 CSF CME Negative 2 XIII B 8 
I72 22 CSF CME Positive XII B 4 
I82 63 Blood FUO Negative 2 XV B 16 
I88 33 CSF HA, AS Positive NDh ND 2 
I91 32 CSF CME Negative III B 4 
I107 65 CSF CME Negative I C 8 
I108 28 CSF CME Negative 1 III B 8 
I113 42 CSF FUO Positive 1 I O 32 
I114f 26 CSF CME Negative 1 X O 0.25 
I116 35 CSF COUGH Positive 1 X O 32 
I118 42 CSF FUO Positive 2 III F 32 
I119 35 CSF CME Negative 2 III B 16 
I120 28 CSF CME Positive VII B 8 
I126 35 CSF FUO, AS Negative III E 8 
ISG12 NAg CSF CME NA XI K 4 a
ISG7 NA CSF CME NA XI N 4 
ISG2 NA CSF CME NA 2 XI N 4 
IJP1 NA NA NA NA 2 III B 4 a
a Age of patient.
b CME, chronic meningoencephalitis.
c HA, headache.
d FUO, fever of unknown origin.
e AS, altered sensorium.
f Serotype D strain.
g NA, not analyzed.
h ND, not determined.
i MIC of fluconazole.
VOL. 43, 2005 C. NEOFORMANS STRAINS FROM INDIA 5735
 o
n
 O
ctober 22, 2015 by University of Queensland Library
http://jcm.asm.org/
D
ow
nloaded from
 
isolate (I114) belonged to group VNIV (C. neoformans var.
neoformans, serotype D), and the remaining 51 isolates be-
longed to group VNI (C. neoformans var. grubii, serotype A).
This identification was confirmed by serotyping (rabbit sera)
with a commercial kit (Iatron, Japan). One isolate, I19-MC,
was untypable by this method. As expected, 90% of the Indian
serotype A and B isolates exhibited a Matmating type. Of the
52 serotype A and D isolates, 50 exhibited a smooth (SM)
colony morphology and 2 isolates exhibited a mucoid (MC)
colony morphology. All serotype B isolates exhibited an MC
colony morphology. Two isolates (I19 and I67) exhibited both
SM- and MC-type colonies. The polysaccharide capsule of all
isolates was measured in an India ink suspension under the
microscope, and the sizes ranged from 0.6 m to 3.7 m. The
capsule size of CSF-derived isolates was comparable to the
capsule size of isolates derived from other locations (2.1 m 
0.4 versus 2.8 m  0.5l; P  0.2). In addition, no significant
decrease in capsule size was documented for sequential iso-
lates from patients where pre- and posttreatment isolates were
available (n 14) (1.7 m 0.6 versus 1.7 m 0.8; P 0.8).
Karyotype analysis. The molecular epidemiology of C. neo-
formans strains from India was investigated by analyzing their
karyotypes by CHEF. Fifty-five C. neoformans isolates from
India revealed 18 distinguishable karyotype patterns (15 pat-
terns for C. neoformans var. grubii and 3 patterns for C. neo-
formans var. gattii). In two isolates (I88 and I90, both derived
from the same patient), sufficient cell lysis could not be
achieved to make chromosomal DNA suitable for CHEF. The
number of chromosomes ranged from 9 to 13 for C. neofor-
mans var. grubii and 10 for C. neoformans var. gattii. Repre-
sentative karyotype patterns are shown in Fig. 1. A large per-
centage (46%) of C. neoformans var. grubii isolates exhibited
karyotype pattern III (34%) or karyotype pattern I (12%)
(excluding sequential isolates). Eight karyotype patterns were
associated with only one isolate, and the other patterns each
were associated with either two or three isolates. The distribu-
tion of karyotype patterns was not different between isolates
from immunocompromised patients or immunocompetent pa-
tients. The average  standard deviation S value for 15 distin-
guishable karyotype patterns (from serotypes A and D) was
0.41  0.1 for 105 comparisons and thus significantly (P 
0.001, by t test) higher than the previously published (24)
average S value of 10 distinguishable karyotype patterns in
New York City isolates (S values, 0.25  0.06 in 44 compari-
sons). In summary, less diversity of electrophoretic karyotypes
was observed among Indian isolates than among New York
City isolates.
RFLP analysis. Indian isolates were also typed by RFLP. All
contained the TCN-1 transposon. TCN-1 RFLP analysis re-
vealed 19 different patterns (patterns A to S) among the 57
isolates. Each pattern exhibited 5 to 13 DNA hybridization
bands for C. neoformans var. grubii and C. neoformans var.
neoformans isolates and 4 to 9 bands for C. neoformans var.
gattii. Representative TCN-1 RFLP patterns are illustrated in
Fig. 2. The hybridization patterns differed greatly from each
other and could be easily distinguished visually. The most
predominant RFLP pattern was pattern B, which included
47% of serotype A isolates (excluding sequential isolates).
Many RFLP patterns (n  12) included only one isolate.
The TCN-1 transposon was also found in the serotype A and
D reference strains (n  7) from other geographical areas.
Although TCN-1 was found in all Indian serotype B strains, it
could not be detected in the majority of C. neoformans var.
gattii strains from other geographical areas. TCN-1 transposon
was not detectable either by Southern blot hybridization with a
TCN-1 probe or by PCR amplification with TCN-specific prim-
ers in genomic DNA of 18 of 20 C. neoformans var. gattii
strains. This collection included 12 serotype B strains from
FIG. 1. Electrophoretic karyotype patterns of Indian C. neoformans
strains. The majority of strains exhibit pattern I or III. (SC is a Saccha-
romyces cerevisiae chromosomal DNA molecular weight marker).
TABLE 2. Characteristics of C. neoformans (serotype B) strains from India
Strain Age(yr)
Source of
sample
Clinical
presentation HIV status
Pattern determined by: MIC
FLU f
Mating
typeCHEF RFLP
I104.97 25 CSF CMEa Negative XVII R 8 
I106.97 30 CSF CME Negative XVII R 8 
I107.97 17 Aspirate NAb Negative XVII R 8 
I49 68 Sputum FUOc Negative XVI P 16 a
I67 (NP-1) 34 CSF ASd, HAe Negative SM-XVIII SM-S 16 
MC-XVIII MC-S 16 
a Chronic meningoencephalitis.
b NA, not determined.
c FUO, fever of unknown origin.
d AS, altered sensorium.
e HA, headache.
f MIC of fluconazole.
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Australia, 5 serotype B strains from Canada, and one serotype
C strain from New York.
URA5 sequence analysis. Twenty-eight Indian strains (sero-
types A and D) were compared with seven New York strains
and five Brazilian strains (Fig. 3). The URA5 sequences of
serotype A strains and one serotype D strain were compared to
those of ATCC 24064 (serotype A), B3501 (serotype D), five
brazilian strains, and seven strains from New York City. The
Indian serotype A strains fell into two major groups (Fig. 3, left
panel). One group included the New York strains, and the
other group included the Brazilian strains. Group 1 contained
28% (8/28) of Indian serotype A isolates (I108, I110, I121,
I114, I116, I113, I57, and I14) and all the New York isolates
(J15, J17, J24, J25, J19, J26, and J21) in addition to B3501.
Neighbor-joining support for this group is 55%. MrBayes
(Bayesian posterior probability [PP], 98%) (Fig. 3, right panel)
and “bootstrapped parsimony” (bootstrap proportion, 51%)
(data not shown) identify a similar group but keep the very
dissimilar I57 and I14 as a separate group. Interestingly, Indian
strains in group 1 that are for the majority serotype A (except
I114) cluster with B3501, a serotype D strain. J21, a New York
serotype A strain, also falls in this group. Relative to ATCC
24064, these strains had a mean number of base substitutions
of 34.4  18.8. Group 2 included 20 Indian strains, 5 Brazilian
strains, and ATCC 24064. The Indian strains within that group
had a mean number of base substitutions of 6.2  3.9 relative
to ATCC 24064. Most differences were found with the third
position of the codon (silent substitutions). Because the introns
are under a different selective pressure, we also analyzed the
sequences after removal of introns and identified a similar
grouping but excluded I57 and I14 for the first group
(MRBayes PP, 76%; data not shown). Both RFLP pattern B
(25% versus 50%, group 1 versus 2) and karyotype pattern III
(12.5 versus 45%, group 1 versus 2) seemed to be more prev-
alent in group 2, although the correlation was not significant by
the chi-square test.
With regard to C. neoformans var. gattii, 4 strains from India,
7 strains from Australia, and 6 strains from North America
(including 5 from Canada) were compared to serotype B ref-
erence strain M93026. These strains clustered to some extent
FIG. 2. RFLP patterns with the TCN-1 probe. Pattern B was the
most common pattern for Indian strains. X denotes a C. neoformans
var. gattii strain (AS 2557) that did not hybridize with the TCN
probe. T is the only Australian C. neoformans var. gattii strain
(AS1337) of 12 that hybridized with the TCN probe. (MW, 1-kb and
100-bp size markers.) The other letters denote RFLP patterns in
C. neoformans strains.
FIG. 3. (Left) A phylogenetic tree of 42 URA5 DNA sequences from C. neoformans serotype A and serotype D isolates was constructed using
the neighbor-joining algorithm (p-distance method) and rooted to ATCC strain 24064. Each number over a branch indicates the percentage of
1,000 bootstrap replicates that support the phylogenetic branch. The bootstrap values of 40% are not shown. Note that Indian strains fall into
separate clusters: one is more closely related to the New York strains, whereas the other strains cluster with the Brazilian strains. (Right) Bayesian
PP, 98% identifies a similar group but keeps I57 and I14 as a separate group.
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according to their geographical origin (data not shown) and
were found to exhibit a mean of 21.7 (range, 1 to 63) base
substitutions in comparison with M93026. These clusters
were maintained regardless of whether the strains carried
the TCN-1 transposon or not. The percentage of identical
sequence within the groups of isolates from a particular
geographical region was 96%  1.9% for Indian strains,
94.2%  1.2% for Canadian strains, and 95.1%  5.4% for
Australian strains.
Microevolution in C. neoformans isolates versus coinfection
with distinct strains. Our strain collection also included a sub-
stantial number (n  18) of sequential isolates from 14 patients,
obtained during the initial diagnosis and persistence of cryptococ-
cal infection (Table 3). For 5 of the 13 patients (for 1 patient,
DNA could not be isolated), evidence for microevolution
could be detected in the electrophoretic karyotypes of their
isolates. In isolates from four patients, these karyotype changes
were minor and involved chromosomal length polymorphisms
in one to three chromosomes. Differences in RFLP patterns
were also detected in 5 strains recovered from these 13 pa-
tients, 3 of which also exhibited changes in karyotype pattern.
In the strains recovered from patient no. 2, karyotype changes
were detected only in the third isolate (I60), whereas the RFLP
patterns were different for all three sequential isolates. Two
isolates recovered from patient 12 4 days apart yielded differ-
ent karyotype and RFLP patterns (Fig. 4A). Strain I114 was
FIG. 4. Differences in karyotype and RFLP pattern are shown between I114 and I117 and between I19-SM and I19-MC. Panel A represents
coinfection with a serotype A strain (I117) (karyotype I, RFLP O pattern) and a serotype D strain (I114) (karyotype IX, RFLP A pattern). Panel
B represents karyotype and RFLP changes between an SM variant (karyotype IV, RFLP N pattern) and an MC variant of I19 (karyotype III, RFLP
M pattern). The immunofluorescence staining of the polysaccharide capsule of the two colony variants revealed differences in binding by MAb
12A1 to the SM (C) and MC (D) polysaccharide capsules. URA5 sequence analysis and sugar assimilation were identical.
TABLE 3. Characteristics of clinical serial C. neoformans isolates from Indiaa
Patient
no. Strains Days apart
Source of
sample
Change in pattern of: Change in MIC
CHEF RFLP FLU AMB
1 I51, I52 d-1 CSF No change No change 16, 16 0.125
2 I55, I56, I60 d-3, d-45 CSF III, III, IV B, C, G 32, 32, 16 0.25
3 I57, I59 d-27 CSF VII, VI G, B 8 0.06, 0.25
4 I61, I63 d-7 CSF No change A, B 8, 16 0.25
5 I66, I73 d-131 CSF IX, I No change 32, 16 0.25, 0.5
6 I68, I74 d-99 CSF XIII, II No change 16, 32 0.125, 0.5
7 I82, I83 d-1 Blood, urine No change No change 16, 8 0.125, 0.06
8 I88, I90 d-14 CSF ND ND 2, 4 0.125
9 I91, I95, I96 d-6, d-15 CSF No change No change 16, 32, 16 0.125
10 I107, I110, I111, I112 d-8, d-8, d-13 CSF, urine No change C, D, C, C 8, 4, 4, 8 0.06, 0.125
11 I108, I109 d-2 CSF No change No change 8, 16 0.5
12 I114, I117 d-4 CSF X, I O, A 32 0.06, 0.125
13 I120, I121 d-5 CSF, blood No change No change 8, 16 0.125
14 I126, I129 d-18 CSF No change No change 8 0.125
a d, day; ND, not determined; FLU, fluconazole; AMB, amphotericin B.
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typed as serotype D and strain I117 as serotype A. The URA5
sequences of the two coinfecting strains differed by 34 nucle-
otides and clustered apart in the phylogenetic tree, consistent
with their difference in varietal identity (Fig. 3). Assimilation
of two sugars also differed between the isolates (data not
shown). For patient 10, we also detected that one of the iso-
lates (I112) recovered from urine at d-13 exhibited changes in
RFLP pattern (C to D), whereas the karyotype pattern was
unchanged. URA5 sequence analysis revealed 33 nucleotide
substitutions between strains I112 and I110, and accordingly,
these were assigned to different clusters. These data also sug-
gest that the strain in the urine was different from the strain
recovered from the CSF. The MICs for amphotericin B and
fluconazole were compared with sequential isolates. Sequen-
tial isolates from patients 3 and 6 exhibited a fourfold increase
in MIC for amphotericin B. No change in MIC was observed
for fluconazole. Interestingly, both sequential isolates with
changed MICs also had karyotype pattern changes in the latter
sequential isolate. The RFLP pattern was changed only in
patient 3.
Variety in colony morphology (SM and MC) was observed
with isolates I19 and I67 (sequential isolates were not avail-
able). With I19, the SM and MC colony phenotypes exhibited
different RFLP and karyotype patterns (Fig. 4B). The URA5
sequences of SM and MC were 	99% identical (1 bp change).
Furthermore, these isolates revealed identical sugar assimila-
tion profiles and were both group VNI (serotype A) by M13
pattern; however, the MC isolate was not typable by the Iatron
kit. Immunofluorescence staining of the polysaccharide cap-
sule of the SM and MC variants of I19 revealed differences in
binding by MAb 12A1 to the SM (Fig. 4C) and MC (Fig. 4D)
polysaccharide capsules. We concluded that they were the
same strain and had undergone significant changes in capsular
phenotype, possibly as a result of phenotypic switching; alter-
natively, they could also be two distinct strains. In summary, we
found evidence of coinfection with two strains for two patients
and evidence for phenotypic microevolution, possibly as a re-
sult of phenotypic switching, for two patients.
DISCUSSION
In this study we investigated the molecular epidemiology of
C. neoformans strains from patients in India. This study was
undertaken because previous work suggested that patients in
India exhibit a greater variety of clinical presentation of
chronic cryptococcosis (2). We drew several important conclu-
sions from our data. (i) Molecular data suggest that Indian
strains are more homogenous than strains from other parts of
the world. (ii) URA5 DNA sequence comparison indicates that
the majority of Indian strains fall into the same group as strains
from Brazil, whereas a smaller fraction clustered with strains
from New York City. (iii) C. neoformans var. gattii strains from
India contain transposon TCN-1, whereas most C. neoformans
var. gattii strains from other parts or the world do not. (iv)
Chronic cryptococcosis can be complicated by microevolution
or coinfection with two distinct C. neoformans strains.
The 57 Indian isolates included in this study were all clinical
isolates and were predominately C. neoformans var. grubii iso-
lates (serotype A) and a small number of C. neoformans var.
gattii isolates (serotype B) and one C. neoformans var. neofor-
mans strain (serotype D). This is consistent with reports that
C. neoformans var. grubii is prevalent among immunosup-
pressed and healthy patients that are afflicted with cryptococ-
cosis (43). It is noteworthy that we recovered only one
C. neoformans var. neoformans (serotype D) isolate from India.
C. neoformans var. neoformans is found primarily in temperate
climates and appears to have lower thermotolerance, which
may reduce its fitness in the tropics (39). Interestingly, more
than half of the isolates were derived from patients that had no
known impairment of their immune system. These findings are
similar to a large survey of cases of cryptococcosis in Australia
and New Zealand, which also found that 30% of the cases
occurred in nonimmunosuppressed individuals and 26% oc-
curred in immunocompromised patients without AIDS (17).
The high proportion of nonimmunocompromised patients may
allow comparisons between the molecular microevolution of
C. neoformans strains over the next years in different patient
populations and the effect of secondary antifungal prophylaxis
in this process.
The Indian isolates were phenotypically similar to those
isolated from other parts of the world. C. neoformans var.
grubii isolates exhibited a smooth colony phenotype, whereas
C. neoformans var. gattii isolates exhibited a mucoid colony
phenotype. For two clinical strain isolates (a C. neoformans
var. gattii isolate and a var. grubii isolate), more than one
colony phenotype was observed in agar. Colony phenotype
variability was also observed for other clinical specimens (25)
and may be the result of phenotypic switching. This number
may underestimate the prevalence of phenotypic variability or
switching, since 2  104 colonies per isolate were screened.
Previous reports indicated that the polysaccharide capsule of
C. neoformans in the brain is smaller than in the lung in a
murine model of cryptococcosis (51), a finding that we could
not confirm in this study. We also could not document a sig-
nificant decrease in capsule size in sequential isolates pre- and
posttreatment, although this had been shown in both in vitro
(56) and in vivo (J. D. Nosanchuk, personal communication)
studies.
Three DNA typing techniques were used to study the mo-
lecular epidemiology of the Indian isolates: electrophoretic
karyotyping, TCN-1 RFLP, and URA5 sequence analysis. De-
pending on the specific geographic area and the molecular
typing technique, studies have shown different degrees of ge-
netic heterogeneity among clinical and environmental isolates
of C. neoformans, even within small geographic areas (6, 18).
Electrophoretic karyotyping is a useful technique for distin-
guishing C. neoformans isolates, because there is great varia-
tion in the size and number of chromosomes among cryp-
tococcal isolates (7, 47, 58). The number of electrophoretic
karyotype patterns among the Indian isolates was lower than
the number in previous studies of North American (34, 46) or
European (20) isolates and similar to the variety reported for
Brazilian strains (13, 22). For example, we found only 18
karyotype patterns among 55 isolates (derived from 39 pa-
tients), whereas Perfect et al. (46) found 41 patterns among 46
isolates and Dromer et al. (20) found 39 patterns among 40
isolates. In contrast, Franzot et al. (22) reported less hetero-
geneity, finding only 14 patterns in 51 isolates, and Calvo et al.,
in another Brazilian study, found 9 patterns in 25 isolates (13).
Differences in CHEF technique do not account for this difference,
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since a previous study from our laboratory in which the same
methods and equipment were used found extensive karyotype
diversity among isolates from one hospital in New York City (24).
In this study we demonstrate that a new RFLP probe, namely
TCN-1, has high discriminatory power among clinical strains. The
median average number of hybridization bands is slightly lower
than that with the CNRE probe. The number of DNA hybrid-
ization bands ranged from 4 to 13, whereas CNRE patterns
typically yield 14 to 20 DNA hybridization bands (53), which
allows rapid and easy visual analysis of the TCN-1 RFLP pat-
terns without computer programs. TCN-1 RFLP patterns ex-
hibit excellent stability with initial and relapse isolates, and the
probe can be easily generated by PCR amplification from cryp-
tococcal DNA. Forty-three percent of the Indian serotype A
isolates yielded one specific RFLP pattern with this TCN
probe (pattern B); similar clustering is observed with the
CNRE probe. This and other studies suggest that certain geo-
graphic areas exhibit less heterogeneity for C. neoformans var.
grubii strains (22). These geographic differences in the molec-
ular epidemiology of C. neoformans could result from natural
selection by specific environmental and climatic conditions at
individual geographic sites. Alternatively, the regions could
have been colonized by different strains (founder effect) to
begin with.
The relative homogeneity of the Indian isolates further sup-
ports the concept that C. neoformans strains have a predomi-
nantly clonal population structure (37). In this regard, the
C. neoformans strains analyzed in this study appear to be dif-
ferent from those of the fungi Coccidioides immitis (12) and
Histoplasma capsulatum (14), which have been reported to
have a recombining population structure. A clonal population
structure for C. neoformans is consistent with several biological
characteristics of this fungus. C. neoformans exists as two het-
erothallic mating types, a and , but sexual reproduction has
been demonstrated only under appropriate laboratory condi-
tions for a few strains. The overwhelming majority of clinical
and environmental serotype A and serotype D isolates are of
the  mating type, which decreases the chance of widespread
sexual recombination in natural populations of C. neoformans
var. neoformans and var. grubii (23, 36). In addition, Wickes et
al. (57) demonstrated that infectious basidiospores could be
generated by haploid fruiting without the occurrence of mei-
osis, which provides another mechanism for clonal reproduc-
tion in C. neoformans varieties neoformans and grubii.
Although C. neoformans var. grubii strains exist predomi-
nately as clonal isolates of the  mating type, there is evidence
from molecular typing studies that certain pathogenic C. neo-
formans strains may be distributed worldwide. In this regard,
parsimony analysis of the URA5 sequences revealed a consen-
sus tree where two-thirds of the Indian isolates fell into a
separate group together with the Brazilian strains and separate
from C. neoformans strains from New York City. Global dis-
persal of certain clones could occur as a result of wind trans-
port and/or bird migrations. Birds like the common pigeon
(Columba livia) were originally found in Europe and North
Africa and have subsequently been introduced throughout the
world by humans (32). Prevalence studies in the pellets of
different avifauna in Madras detected Cryptococcus neofor-
mans in 13.5% of pigeon droppings, 9.1% of fowl pellets, and
11.3% of crow droppings (27). Although the fungus does not
colonize the gastrointestinal tract because of the higher body
temperature, it can also be isolated from the beaks or the feet
of pigeons (16). Both karyotyping and RFLP typing demon-
strated the dominance of one pattern (III and B) in group 2. A
statistically significant correlation between the molecular typ-
ing results could not be obtained. This may be due to a lack of
power or may suggest that molecular typing techniques define
independent molecular differences.
In contrast, C. neoformans var. gattii strains have a more
restricted environmental niche. C. neoformans var. gattii is not
associated with bird excreta but occurs in a varieties of trees
including several Eucalyptus spp. (52). As with varieties neo-
formans and grubii, the population structure of variety gattii
strains appears to be predominantly clonal, although both mat-
ing types exist and can generate new clades (23, 28). The
majority of C. neoformans var. gattii strains are not fertile and
cannot generate haploid spores by monokaryotic fruiting (57).
Thus, C. neoformans var. gattii strains may not disperse as
widely as those of variety neoformans and grubii, which may
explain why the TCN element was not found in most strains,
especially if sexual recombination is rare, as suggested by mo-
lecular typing studies with Australian strains (28). As deter-
mined by URA5 sequence analysis, strains from the same geo-
graphical region tended to be more homologous.
We found a significant increase in MIC of amphotericin B in
sequential isolates of 2 patients of 14 patients in whom sequen-
tial isolates were available. This number is slightly higher than
previously reported (9, 11). Of note is that both strains also
exhibited changes in karyotype patterns. Our data also show
that human cryptococcosis can result from simultaneous in-
fection with two strains, which may complicate treatment and
contribute to failure. This observation appears to be the sec-
ond well-documented case of human coinfection with two
strains after the report by Haynes et al. (30). In addition,
cryptococcosis in humans manifests as a chronic disease, and
patients often are infected for weeks or months during which
the fungus can undergo microevolution. During chronic infec-
tion, the host represents an environment that will promote
selection of specific variants that result from microevolution.
Microevolution is inherently difficult to identify and quantify
(24). Nevertheless, careful analysis of sequential isolates in our
study confirmed that C. neoformans strains undergo significant
diversification in vivo as a result of microevolution. Significant
karyotype changes have been previously described for switch-
ing Candida albicans and C. neoformans strains (26, 45). Inter-
estingly, the recently published genome sequence of C. neofor-
mans demonstrates that the genome is rich in transposons,
many of which cluster at candidate centrometric regions (38).
To what extent transposable elements could play a role in
microevolution is unclear, and future studies are warranted to
delineate the importance of this transposable element for the
biology of this fungus.
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